Author Question: In the type of mixed design in which both manipulated and nonmanipulated factors are included, the ... (Read 14 times)

cmoore54

  • Hero Member
  • *****
  • Posts: 568
In the type of mixed design in which both manipulated and nonmanipulated factors are included, the critical issue is
 
  A) a statistical one.
  B) to use care in interpretation of results.
  C) to interpret main effects before interactions.
  D) to make sure the same number of participants is used in each group.

Question 2

In the type of mixed design in which both between-subjects and within-subjects factors exist in the same study, the critical issue is
 
  A) that the statistical procedures must take into account the correlated nature of some of the data.
  B) one of interpretation of results rather than statistical procedures themselves.
  C) making sure that the data are entered in the correct order, with the between-subjects data entered first.
  D) making sure participants are assigned in a random fashion.



prumorgan

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

Answer: B

Answer to Question 2

Answer: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

For a complete list of videos, visit our video library